L’Oréal, a French multinational personal care company, agreed to acquire a 10% of stake in Galderma, a Swiss pharmaceutical company specializing in dermatological treatments and skin care products, from EQT, a Swedish global investment organization, and Abu Dhabi Investment Authority, a sovereign wealth fund owned by the Emirate of Abu Dhabi in the United Arab Emirates. Financial terms were not disclosed. “This transaction is part of our strategy to continue supporting Galderma on its outstanding growth journey in the attractive dermatology market. We remain committed to Galderma and will continue managing our investment in the best interest of all its shareholders. Selling a minority stake to a reputable strategic partner such as L’Oréal, the global leader in Beauty, is a direct reflection of our commitment,” Michael Bauer, EQT Partner and Co-Head of Global Healthcare Sector.